FDA clears next generation VISIUS surgical theatre


IMRIS has announced US Food and Drug Administration (FDA) clearance of the newest generation VISIUS surgical theatre which integrates Siemens’ latest high-field magnetic resonance (MR) scanners.

According to a press release, the new core imaging technology based on Siemens Aera 1.5T (tesla) and Skyra 3.0T technology helps IMRIS deliver better image quality with higher signal-to-noise ratio, faster 3D image acquisition, and improved ease-of-use and workflow during neurosurgical procedures using intraoperative magnetic resonance imaging (iMRI).

The addition of these MR systems expands the industry-leading 1.5T and 3.0T MRI choices hospitals have when considering the unique, ceiling-mounted IMRIS solution for intraoperative imaging which brings the MRI to the patient during the procedure.

The first installation of this new generation VISIUS surgical theatre will be a four-room hybrid operating room suite, known as the Centre for Surgical Innovation at Dartmouth-Hitchcock Medical Centre in Lebanon, New Hampshire, USA. “Surgeons are too often limited by what they cannot see – anatomy that is difficult to reach or diseases that are not visible to the naked eye,” says Sohail Mirza, medical director of the Centre for Surgical Innovation and chair of orthopaedics at Dartmouth-Hitchcock. “The advanced integration of state-of-the-art imaging tools in the Centre for Surgical Innovation will allow surgeons and engineers to innovate like never before, rapidly developing, testing, and validating new surgical tools and techniques, with the goal of achieving better, safer, and, in some cases, less-costly care for patients everywhere.”

The Dartmouth-Hitchcock installation will also include a VISIUS intraoperative computerised tomography (iCT), which utilises the technology of the 64-slice Siemens SOMATOM Definition AS scanner, making it the only operating suite in the world with both VISIUS iMRI and iCT modalities able to serve multiple operating rooms without moving the patient, the press release reports.